Io Therapeutics, Inc., a privately held pharmaceutical company headquartered in Spring, Texas; announced today presentation at the San Antonio Breast Cancer Symposium, in San Antonio, TX; of data from ...

Cancer vaccines' efficacy can be tested on an organ-on-a-chip platform that replicates age-related immune decline.

Approval based on phase II NOBILITY and phase III REGENCY studies showing superiority of Gazyva/Gazyvaro over standard ...

Learn how Logic-gated DARPins work to activate T cells selectively in solid tumours, enhancing therapeutic outcomes.

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the presentation of new preclinical data on ...

Rondo Therapeutics begins patient dosing in phase 1/1b trial of RNDO-564 in adults with r/r locally advanced or metastatic urothelial carcinoma: Hayward, California Saturday, Dece ...

Orna Therapeutics (Orna), a biotechnology company dedicated to engineering immune cells in vivo to treat autoimmune and oncology diseases, today announced new preclinical data supporting the Company's ...

This study measured real-life PFAS concentrations in first-trimester human placentas and used these data to create a ...